CVS Health CorpEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 105.22 USD | 110 USD | 59,308 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 112,192 USD | 18 | 6 | 4 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 1.275.927.307 | 1,54 | 2,47 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name CVS Health Corp
Mitarbeiter 219.000
Handelsplatz NYSE
Ticker Symbol CVS
IPO Datum 1984-12-17
Adresse One CVS Drive, Woonsocket, RI, United States, 02895
Webseite https://www.cvshealth.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. J. David Joyner CEBS | CEO, President & Chairman |
| 2 | Mr. Brian O. Newman | Executive VP & CFO |
| 3 | Mr. Tilak Mandadi | EVP of Ventures and Chief Experience & Technology Officer |
| 4 | Mr. Prem S. Shah Pharm.D | Executive VP & Group President |
| 5 | Mr. Steven Hale Nelson M.B.A. | Executive VP & President of Aetna |
| 6 | Mr. James David Clark | Senior VP, Controller & Chief Accounting Officer |
| 7 | Mr. David A. Falkowski | Executive VP & Chief Compliance Officer |
| 8 | Ms. Heidi B. Capozzi | Executive VP & Chief People Officer |
| 9 | Mr. Gustavo A. Giraldo | Head of Markets of Healthcare Benefits |
| 10 | Ms. Sheryl A. Burke | Chief Sustainability Officer & Senior VP of Corporate Social Responsibility |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 9,87% | 13,34 Mrd. USD |
| 2 | Vanguard Group Inc | 9,46% | 12,79 Mrd. USD |
| 3 | Vanguard Capital Management, LLC | 6,48% | 8,75 Mrd. USD |
| 4 | Capital World Investors | 6,05% | 8,18 Mrd. USD |
| 5 | State Street Corp | 4,65% | 6,28 Mrd. USD |
| 6 | Dodge & Cox | 4,06% | 5,49 Mrd. USD |
| 7 | FMR Inc | 2,44% | 3,30 Mrd. USD |
| 8 | JPMorgan Chase & Co | 2,31% | 3,13 Mrd. USD |
| 9 | Geode Capital Management, LLC | 2,31% | 3,12 Mrd. USD |
| 10 | Vanguard Portfolio Management, LLC | 2,04% | 2,75 Mrd. USD |
| 11 | Amvescap Plc. | 1,97% | 2,66 Mrd. USD |
| 12 | T. Rowe Price Associates, Inc. | 1,86% | 2,52 Mrd. USD |
| 13 | Wellington Management Company LLP | 1,77% | 2,39 Mrd. USD |
| 14 | NORGES BANK | 1,65% | 2,22 Mrd. USD |
| 15 | Capital Research Global Investors | 1,57% | 2,12 Mrd. USD |
| 16 | Morgan Stanley - Brokerage Accounts | 1,40% | 1,89 Mrd. USD |
| 17 | Capital Research & Mgmt Co - Division 3 | 1,21% | 1,63 Mrd. USD |
| 18 | Pzena Investment Management, LLC | 1,08% | 1,46 Mrd. USD |
| 19 | Charles Schwab Investment Management Inc | 1,07% | 1,45 Mrd. USD |
| 20 | The Goldman Sachs Group Inc | 0,99% | 1,34 Mrd. USD |